JP2024521063A5 - - Google Patents

Info

Publication number
JP2024521063A5
JP2024521063A5 JP2023570195A JP2023570195A JP2024521063A5 JP 2024521063 A5 JP2024521063 A5 JP 2024521063A5 JP 2023570195 A JP2023570195 A JP 2023570195A JP 2023570195 A JP2023570195 A JP 2023570195A JP 2024521063 A5 JP2024521063 A5 JP 2024521063A5
Authority
JP
Japan
Prior art keywords
serotype
associated virus
adeno
recombinant adeno
virus genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023570195A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521063A (ja
Filing date
Publication date
Priority claimed from EP21382441.0A external-priority patent/EP4089171A1/en
Application filed filed Critical
Publication of JP2024521063A publication Critical patent/JP2024521063A/ja
Publication of JP2024521063A5 publication Critical patent/JP2024521063A5/ja
Pending legal-status Critical Current

Links

JP2023570195A 2021-05-12 2022-05-12 Tertをコードする組換えウイルスゲノム及びウイルスベクター Pending JP2024521063A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21382441.0A EP4089171A1 (en) 2021-05-12 2021-05-12 Recombinant tert-encoding viral genomes and vectors
EP21382441.0 2021-05-12
PCT/EP2022/062990 WO2022238557A1 (en) 2021-05-12 2022-05-12 Recombinant tert-encoding viral genomes and vectors

Publications (2)

Publication Number Publication Date
JP2024521063A JP2024521063A (ja) 2024-05-28
JP2024521063A5 true JP2024521063A5 (enExample) 2025-05-20

Family

ID=75919286

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023570195A Pending JP2024521063A (ja) 2021-05-12 2022-05-12 Tertをコードする組換えウイルスゲノム及びウイルスベクター

Country Status (9)

Country Link
US (2) US20250099618A1 (enExample)
EP (2) EP4089171A1 (enExample)
JP (1) JP2024521063A (enExample)
CN (1) CN117836420A (enExample)
AU (1) AU2022273863A1 (enExample)
CA (1) CA3219795A1 (enExample)
ES (1) ES3073712T3 (enExample)
MX (1) MX2023013385A (enExample)
WO (1) WO2022238557A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12668817B1 (en) * 2025-07-10 2026-06-30 Telomere Therapeutics S.L. Recombinant adeno-associated viral vectors for delivering a therapeutic gene to lungs

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
CA2188157A1 (en) * 1994-05-18 1995-11-23 Children's Hospital Medical Center Nucleic acid sequences controlling lung cell-specific gene expression
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
US5741683A (en) 1995-06-07 1998-04-21 The Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
US5952221A (en) 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
EP1007637B1 (en) 1997-04-14 2004-06-30 Cell Genesys, Inc. Methods for increasing the efficiency of recombinant aav product
US6207455B1 (en) 1997-05-01 2001-03-27 Lung-Ji Chang Lentiviral vectors
CN1247788C (zh) 1997-05-13 2006-03-29 北卡罗来纳-查佩尔山大学 基于慢病毒的基因转移载体
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6218181B1 (en) 1998-03-18 2001-04-17 The Salk Institute For Biological Studies Retroviral packaging cell line
US6146874A (en) 1998-05-27 2000-11-14 University Of Florida Method of preparing recombinant adeno-associated virus compositions
EP1135468B1 (en) 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
DE19909769A1 (de) 1999-03-05 2000-09-07 Bundesrepublik Deutschland Let Von SIVagm abgeleitete lentivirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in Säugerzellen
AU6814901A (en) 2000-06-01 2001-12-11 Univ North Carolina Methods and compounds for controlled release of recombinant parvovirus vectors
AU2003274397A1 (en) 2002-06-05 2003-12-22 University Of Florida Production of pseudotyped recombinant aav virions
US20080188431A1 (en) * 2004-09-08 2008-08-07 Chiorini John A Transcytosis of Adeno-Associated Viruses
ES2590461T3 (es) * 2010-07-02 2016-11-22 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii La transcriptasa inversa de la telomerasa como protección frente al envejecimiento
US9453209B2 (en) * 2012-12-27 2016-09-27 Sierra Sciences, Llc Enhancing health in mammals using telomerase reverse transcriptase gene therapy
ES2936383T3 (es) 2014-08-08 2023-03-16 Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio Terapias basadas en transcriptasa inversa de la telomerasa para el tratamiento de afecciones asociadas con el infarto de miocardio
EP3485914B1 (en) 2014-08-08 2021-01-13 Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) Telomerase reverse transcriptase-based therapies

Similar Documents

Publication Publication Date Title
JP2022500066A5 (enExample)
JP2024054426A5 (enExample)
JP2023512519A5 (enExample)
JP2020203894A5 (enExample)
JP2023109992A5 (enExample)
JP2025184979A5 (enExample)
JP2018537984A5 (enExample)
JP2023100654A5 (enExample)
JP2022505877A5 (enExample)
JP2022522996A5 (enExample)
JP2023526073A5 (enExample)
JP2020518268A5 (enExample)
JP2022530833A5 (enExample)
JP2022513308A5 (enExample)
JP2010516252A5 (enExample)
JP2023517934A5 (enExample)
JP2021500922A5 (enExample)
JP2020172505A5 (enExample)
JP2018537089A5 (enExample)
JP2024545183A5 (enExample)
JP2023535121A5 (enExample)
JP2024513907A5 (enExample)
JP2025107171A5 (enExample)
JP2025508676A5 (enExample)
JP2023536570A5 (enExample)